Nonhuman primate models for cell-Associated simian immunodeficiency virus transmission: The need to better understand the complexity of HIV mucosal transmission

Journal of Infectious Diseases

Volumn 210, Issue , 2014, Pages S660-S666

  Bernard Stoecklin, Sibylle ^a,b   Gommet, Céline ^a,b   Cavarelli, Mariangela ^a,b,c   Le Grand, Roger ^a,b  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Cell Associated virus; HIV; Leukocytes.; Mucosal transmission; Non human primate; Semen; SIV

Indexed keywords

ANIMAL; CYTOLOGY; DISEASE MODEL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE; MACACA; MALE; MUCOSA; PHYSIOLOGY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; SPERM; TRANSMISSION; VAGINA; VIROLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HIV; HIV INFECTIONS; HUMANS; LEUKOCYTES; MACACA; MALE; MUCOUS MEMBRANE; SEMEN; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VAGINA;

EID: 84925225346     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu536     Document Type: Article

References (55)

1. Li Q, Estes JD, Schlievert PM, et al. Glycerol monolaurate prevents mucosal SIV transmission. Nature 2009; 458:1034-8.
2. Couedel-Courteille A, Pretet JL, Barget N, et al. Delayed viral replication and CD4(+) T cell depletion in the rectosigmoid mucosa of macaques during primary rectal SIV infection. Virology 2003; 316:290-301.
3. Miller CJ, Li Q, Abel K, et al. Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J Virol 2005; 79:9217-27.
4. Pilch B, Mann M. Large-scale and high-confidence proteomic analysis of human seminal plasma. Genome Biol 2006; 7:R40.
5. Belec L, Georges AJ, Steenman G, Martin PM. Antibodies to human immunodeficiency virus in the semen of heterosexual men. J Infect Dis 1989; 159:324-7.
6. Sabatte J, Ceballos A, Raiden S, et al. Human seminal plasma abrogates the capture and transmission of human immunodeficiency virus type 1 to CD4+ T cells mediated by DC-SIGN. J Virol 2007; 81:13723-34.
7. Usmani SM, Zirafi O, Muller JA, et al. Direct visualization of HIV-enhancing endogenous amyloid fibrils in human semen. Nat Commun 2014; 5:3508.
8. Roan NR, Muller JA, Liu H, et al. Peptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV infection. Cell Host Microbe 2011; 10:541-50.
9. Balandya E, Sheth S, Sanders K, Wieland-Alter W, Lahey T. Semen protects CD4+ target cells from HIV infection but promotes the preferential transmission of R5 tropic HIV. J Immunol 2010; 185: 7596-604.
10. Munch J, Sauermann U, Yolamanova M, Raue K, Stahl-Hennig C, Kirchhoff F. Effect of semen and seminal amyloid on vaginal transmission of simian immunodeficiency virus. Retrovirology 2013; 10:148.
11. Rudnicka D, Feldmann J, Porrot F, et al. Simultaneous cell-To-cell transmission of human immunodeficiency virus to multiple targets through polysynapses. J Virol 2009; 83:6234-46.
12. Politch JA, Mayer KH, Anderson DJ. Depletion of CD4+ T cells in semen during HIV infection and their restoration following antiretroviral therapy. J Acquir Immune Defic Syndr 2009; 50:283-9.
13. Anderson DJ, Politch JA, Nadolski AM, Blaskewicz CD, Pudney J, Mayer KH. Targeting Trojan Horse leukocytes for HIV prevention. AIDS 2010; 24:163-87.
14. Anderson DJ, OBrien TR, Politch JA, et al. Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type 1 in semen. JAMA 1992; 267:2769-74.
15. Quayle AJ, Xu C, Mayer KH, Anderson DJ. T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen. J Infect Dis 1997; 176:960-8.
16. Bernard-Stoecklin S, Gommet C, Corneau AB, et al. Semen CD4+ T cells and macrophages are productively infected at all stages of SIV infection in macaques. PLoS Pathog 2013; 9:e1003810.
17. Olivier AJ, Liebenberg LJ, Coetzee D, Williamson AL, Passmore JA, BurgersWA. Isolation and characterization of T cells from semen. J Immunol Methods 2012; 375:223-31.
18. Ganor Y, Zhou Z, Bodo J, et al. The adult penile urethra is a novel entry site for HIV-1 that preferentially targets resident urethral macrophages. Mucosal Immunol 2013; 6:776-86.
19. Carreno MP, Chomont N, Kazatchkine MD, et al. Binding of LFA-1 (CD11a) to intercellular adhesion molecule 3 (ICAM-3; CD50) and ICAM-2 (CD102) triggers transmigration of human immunodeficiency virus type 1-infected monocytes through mucosal epithelial cells. J Virol 2002; 76:32-40.
20. Jolly C, Mitar I, Sattentau QJ. Adhesion molecule interactions facilitate human immunodeficiency virus type 1-induced virological synapse formation between T cells. J Virol 2007; 81:13916-21.
21. Rudnicka D, Schwartz O. Intrusive HIV-1-infected cells. Nat Immunol 2009; 10:933-4.
22. Fultz PN, Nara P, Barre-Sinoussi F, et al. Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells. Science 1992; 256:1687-90.
23. Girard M, Mahoney J, Wei Q, et al. Genital infection of female chimpanzees with human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 1998; 14:1357-67.
24. Osterhaus A, de Vries P, Morein B, Akerblom L, Heeney J. Comparison of protection afforded by whole virus ISCOM versus MDP adjuvanted formalin-inactivated SIV vaccines from IV cell-free or cell-Associated homologous challenge. AIDS Res Hum Retroviruses 1992; 8:1507-10.
25. Heeney JL, de Vries P, Dubbes R, et al. Comparison of protection from homologous cell-free vs cell-Associated SIV challenge afforded by inactivated whole SIV vaccines. J Med Primatol 1992; 21:126-30.
26. Almond N, Kent K, Cranage M, Rud E, Clarke B, Stott EJ. Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet 1995; 345:1342-4.
27. Heeney JL, van Els C, de Vries P, et al. Major histocompatibility complex class I-Associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells. J Exp Med 1994; 180:769-74.
28. Girard M, van der Ryst E, Barre-Sinoussi F, et al. Challenge of chimpanzees immunized with a recombinant canarypox-HIV-1 virus. Virology 1997; 232:98-104.
29. Ignatius R, Tenner-Racz K, Messmer D, et al. Increased macrophage infection upon subcutaneous inoculation of rhesus macaques with simian immunodeficiency virus-loaded dendritic cells or T cells but not with cell-free virus. J Virol 2002; 76:9787-97.
30. Sodora DL, Gettie A, Miller CJ, Marx PA. Vaginal transmission of SIV: Assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-Associated viral stocks. AIDS Res Hum Retroviruses 1998; 14(suppl 1):S119-23.
31. Kaizu M, Weiler AM, Weisgrau KL, et al. Repeated intravaginal inoculation with cell-Associated simian immunodeficiency virus results in persistent infection of nonhuman primates. J Infect Dis 2006; 194:912-6.
32. Weiler AM, Li Q, Duan L, et al. Genital ulcers facilitate rapid viral entry and dissemination following intravaginal inoculation with cell-Associated simian immunodeficiency virus SIVmac239. J Virol 2008; 82: 4154-8.
33. Salle B, Brochard P, Bourry O, et al. Infection of macaques after vaginal exposure to cell-Associated simian immunodeficiency virus. J Infect Dis 2010; 202:337-44.
34. Di Fabio S, Giannini G, Lapenta C, et al. Vaginal transmission of HIV-1 in hu-SCID mice: A new model for the evaluation of vaginal microbicides. AIDS 2001; 15:2231-8.
35. Kolodkin-Gal D, Hulot SL, Korioth-Schmitz B, et al. Efficiency of cellfree and cell-Associated virus in mucosal transmission of human immunodeficiency virus type 1 and simian immunodeficiency virus. J Virol 2013; 87:13589-97.
36. Bergmeier LA, Babaahmady K, Wang Y, Lehner T. Mucosal alloimmunization elicits T-cell proliferation, CC chemokines, CCR5 antibodies and inhibition of simian immunodeficiency virus infectivity. J Gen Virol 2005; 86:2231-8.
37. Le Grand R, Vaslin B, Vogt G, Roques P, Humbert M, Dormont D. AIDS vaccine developments. Nature 1992; 355:684.
38. Le Grand R, Vogt G, Vaslin B, et al. Specific and non-specific immunity and protection of macaques against SIV infection. Vaccine 1992; 10: 873-9.
39. Cranage MP, Ashworth LA, Greenaway PJ, Murphey-Corb M, Desrosiers RC. AIDS vaccine developments. Nature 1992; 355:685-6.
40. Stott EJ. Anti-cell antibody in macaques. Nature 1991; 353:393.
41. Miller CJ, Alexander NJ, Sutjipto S, et al. Genital mucosal transmission of simian immunodeficiency virus: Animal model for heterosexual transmission of human immunodeficiency virus. J Virol 1989; 63: 4277-84.
42. Doncel GF, Joseph T, Thurman AR. Role of semen in HIV-1 transmission: inhibitor or facilitator? Am J Reprod Immunol 2011; 65:292-301.
43. Le Grand R, Nadal M, Cheret A, et al. Infection of macaques after vaginal exposure to a primary isolate of SIVmac251. AIDS 1995; 9:308-9.
44. Owen DH, Katz DF. A review of the physical and chemical properties of human semen and the formulation of a semen simulant. J Androl 2005; 26:459-69.
45. Olivier AJ, Masson L, Ronacher K, et al. Distinct cytokine patterns in semen influence local HIV shedding and HIV target cell activation. J Infect Dis 2014; 209:1174-84.
46. Sabatte J, Faigle W, Ceballos A, et al. Semen clusterin is a novel DCSIGN ligand. J Immunol 2011; 187:5299-309.
47. Doyle L, Young CL, Jang SS, Hillier SL. Normal vaginal aerobic and anaerobic bacterial flora of the rhesus macaque (Macaca mulatta). J Med Primatol 1991; 20:409-13.
48. Patton DL, Cosgrove-Sweeney YT, Rabe LK, Hillier SL. The pig-Tailed macaque rectal model: microflora and chlamydial infection. Sex Transm Dis 2001; 28:363-6.
49. Kempf C, Jentsch P, Barre-Sinoussi FB, et al. Inactivation of human immunodeficiency virus (HIV) by low pH and pepsin. J Acquir Immune Defic Syndr 1991; 4:828-30.
50. Spear GT, Gilbert D, Sikaroodi M, et al. Identification of rhesus macaque genital microbiota by 16S pyrosequencing shows similarities to human bacterial vaginosis: implications for use as an animal model for HIV vaginal infection. AIDS Res Hum Retroviruses 2010; 26:193-200.
51. Patton DL, Sweeney YC, Cummings PK, Meyn L, Rabe LK, Hillier SL. Safety and efficacy evaluations for vaginal and rectal use of BufferGel in the macaque model. Sex Transm Dis 2004; 31:290-6.
52. Sharkey DJ, Macpherson AM, Tremellen KP, Robertson SA. Seminal plasma differentially regulates inflammatory cytokine gene expression in human cervical and vaginal epithelial cells. Mol Hum Reprod 2007; 13:491-501.
53. Politch JA, Tucker L, Bowman FP, Anderson DJ. Concentrations and significance of cytokines and other immunologic factors in semen of healthy fertile men. Hum Reprod 2007; 22:2928-35.
54. Robertson SA, Guerin LR, Bromfield JJ, Branson KM, Ahlstrom AC, Care AS. Seminal fluid drives expansion of the CD4+CD25+ T regulatory cell pool and induces tolerance to paternal alloantigens in mice. Biol Reprod 2009; 80:1036-45.
55. Houzet F, Matusali G, Dejucq-Rainsfor D. Origins of HIV-infected leukocytes and virions in semen. J Infect Dis 2014; 210(suppl 3):S622-30.